MB-CART20.1 Lymphoma

NCT03664635 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
10
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Miltenyi Biomedicine GmbH